Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
Courlet P, Cardoso E, Bandiera C, Stravodimou A, Zurcher JP, Chtioui H, Locatelli I, Decosterd LA, Darnaud L, Blanchet B, Alexandre J, Wagner AD, Zaman K, Schneider MP, Guidi M, Csajka C. Courlet P, et al. Among authors: zaman k. Pharmaceutics. 2022 Jun 21;14(7):1317. doi: 10.3390/pharmaceutics14071317. Pharmaceutics. 2022. PMID: 35890213 Free PMC article.
An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E, Mercier T, Zanolari B, Cruchon S, Guignard N, Buclin T, Leyvraz S, Zaman K, Csajka C, Decosterd LA. Dahmane E, et al. Among authors: zaman k. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Dec 15;878(32):3402-14. doi: 10.1016/j.jchromb.2010.10.027. Epub 2010 Oct 30. J Chromatogr B Analyt Technol Biomed Life Sci. 2010. PMID: 21094101
Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology.
Dahmane E, Boccard J, Csajka C, Rudaz S, Décosterd L, Genin E, Duretz B, Bromirski M, Zaman K, Testa B, Rochat B. Dahmane E, et al. Among authors: zaman k. Anal Bioanal Chem. 2014 Apr;406(11):2627-40. doi: 10.1007/s00216-014-7682-2. Epub 2014 Mar 16. Anal Bioanal Chem. 2014. PMID: 24633563
Therapeutic drug monitoring of targeted anticancer therapy.
Decosterd LA, Widmer N, Zaman K, Cardoso E, Buclin T, Csajka C. Decosterd LA, et al. Among authors: zaman k. Biomark Med. 2015;9(9):887-93. doi: 10.2217/bmm.15.78. Epub 2015 Sep 3. Biomark Med. 2015. PMID: 26333311 Review.
[Advances in Oncology 2019].
Vernadou A, Ferahta N, Mederos N, Ferraro D, Dischl-Antonioni I, Diciolla A, Liapi A, Mosimann V, Latifyan S, Aedo-Lopez V, Berthold D, Digklia A, Michielin O, Montemurro M, Wagner AD, Zaman K, Peters S, Stravodimou A, Sarivalasis A. Vernadou A, et al. Among authors: zaman k. Rev Med Suisse. 2020 Jan 15;16(676-7):72-77. Rev Med Suisse. 2020. PMID: 31961089 Review. French.
737 results